LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -25.0% | 10,725 | -0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 10,726 | -11.6% | 0.00% | – |
| Q1 2022 | $8,000 | -75.0% | 12,133 | -12.8% | 0.00% | – |
| Q4 2021 | $32,000 | -34.7% | 13,907 | +30.1% | 0.00% | – |
| Q3 2021 | $49,000 | -38.8% | 10,692 | -40.8% | 0.00% | – |
| Q2 2021 | $80,000 | +21.2% | 18,055 | +99.2% | 0.00% | – |
| Q1 2021 | $66,000 | -63.5% | 9,064 | -61.8% | 0.00% | – |
| Q4 2020 | $181,000 | +178.5% | 23,735 | +233.0% | 0.00% | – |
| Q3 2020 | $65,000 | +16.1% | 7,128 | +6.2% | 0.00% | – |
| Q2 2020 | $56,000 | +229.4% | 6,715 | +94.0% | 0.00% | – |
| Q1 2020 | $17,000 | -94.5% | 3,462 | -92.0% | 0.00% | – |
| Q4 2019 | $311,000 | +677.5% | 43,203 | +1068.3% | 0.00% | – |
| Q3 2019 | $40,000 | – | 3,698 | +13107.1% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 28 | -98.1% | 0.00% | – |
| Q1 2019 | $14,000 | -89.1% | 1,439 | -88.4% | 0.00% | – |
| Q4 2018 | $129,000 | – | 12,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |